Spruce Biosciences (SPRB)
Develops an enzyme therapy for Sanfilippo syndrome and a preclinical CAH antibody.
$48.63
vs last close−1.36 (−2.72%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 47 days
EPS estimate
−$5.68
Revenue estimate
$50.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$42.75−$24.00−$3.50−$14.58−$9.58−$8.94−$6.68Pending
Estimate−$0.24−$18.80−$18.00−$15.56−$12.87−$7.32−$5.79−$5.68
Surprise−17,712.1%−27.7%+80.6%+6.3%+25.6%−22.1%−15.4%—
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$700.0K——————Pending
Estimate$885.0K$250.0K$500.0K$500.0K$500.0K——$50.0M
Surprise−20.9%———————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$4.53 | — | — |
| Sep 2027 | $15.05 | — | — |
| Jun 2027 | −$5.94 | — | — |
| Mar 2027 | −$5.84 | — | — |
| Dec 2026 | −$5.34 | — | — |
| Nov 2026 | −$5.68 | — | — |
| Aug 2026 | −$5.79 | −$6.68 | −15.4% |
| May 2026 | −$7.32 | −$8.94 | −22.1% |
| Mar 2026 | −$12.87 | −$9.58 | +25.6% |
| Nov 2025 | −$15.56 | −$14.58 | +6.3% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$4.53 | — | — | $5.2M | — | — | — |
| Sep 2027 | $15.05 | — | — | $89.1M | — | — | — |
| Jun 2027 | −$5.94 | — | — | $0 | — | — | — |
| Mar 2027 | −$5.84 | — | — | $0 | — | — | — |
| Dec 2026 | −$5.34 | — | — | $3.8M | — | — | — |
| Nov 9, 2026 | −$5.68 | — | — | $50.0M | — | — | — |
| Aug 12, 2026 | −$5.79 | −$6.68 | −15.4% | — | — | — | +1.4% |
| May 13, 2026 | −$7.32 | −$8.94 | −22.1% | — | — | — | +1.6% |
| Mar 9, 2026 | −$12.87 | −$9.58 | +25.6% | $500.0K | — | — | +11.2% |
| Nov 10, 2025 | −$15.56 | −$14.58 | +6.3% | $500.0K | — | — | −9.0% |
| Aug 15, 2025 | |||||||
| May 6, 2025 | |||||||
| Apr 15, 2025 | |||||||
| Nov 11, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 22, 2021 | |||||||
| Nov 18, 2020 | |||||||
| Oct 9, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |